Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Articles

Page Path
HOME > J Mov Disord > Early view > Article
Erratum
 Efficacy and Safety of Taltirelin Hydrate in Patients With Ataxia Due to Spinocerebellar Degeneration
Jin Whan Cho1, Jee-Young Lee2, Han-Joon Kim3, Joong-Seok Kim4, Kun-Woo Park5, Seong-Min Choi6, Chul Hyoung Lyoo7, Seong-Beom Koh8
> Epub ahead of print
DOI: https://doi.org/10.14802/jmd.24127e
Published online: February 20, 2026

1Department of Neurology, Samsung Seoul Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

2Department of Neurology, SMG-SNU Boramae Medical Center, Seoul, Korea

3Department of Neurology, Seoul National University College of Medicine, Seoul, Korea

4Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Korea

5Department of Neurology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea

6Department of Neurology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea

7Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea

8Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea

Copyright © 2026 The Korean Movement Disorder Society

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 376 Views
  • 5 Download
Full Article

Download PDF Download PDF

This corrects the article "Efficacy and Safety of Taltirelin Hydrate in Patients With Ataxia Due to Spinocerebellar Degeneration" on page 35.
J Mov Disord 2025;18(1):35-44
The publisher and authors would like to draw the reader’s attention to errors in the above article.

  • 1. On page 36, in the Exclusion criteria section, item 7 was incorrectly stated. The Korean Mini-Mental State Examination (K-MMSE) score criterion was originally reported as ≥20, but the correct criterion is ≤20. The corrected part is underlined in the revised text below.

    7) patients with cognitive dysfunction, as evidenced by a Korean Mini-Mental State Examination (K-MMSE) score ≤20

  • 2. On page 38, in Table 1, the term “Hereditary spastic ataxia” was incorrect and should be corrected to “Hereditary spastic paraplegia.” The correction is underlined in the revised table.

The authors apologize for these errors.
Table 1.
Baseline characteristics of the patients
Variables Values
 p value
Taltirelin group (n=75) Control group (n=74)
Age (yr) 56.60±10.55 52.51±12.17 0.0265*
Sex 0.9385
 Men 40 (53.33) 39 (52.70)
 Women 35 (46.67) 35 (47.30)
Genetic inheritance of ataxia 0.6927
 Hereditary ataxia 41 (54.67) 45 (60.81)
  SCA 37 (49.33) 42 (56.76)
  Other types of hereditary ataxia 4 (5.33) 3 (4.05)
   Spastic ataxia of Charlevoix-Saguenay 0 (0.00) 1 (1.35)
   Hereditary spastic paraplegia 1 (1.33) 0 (0.00)
   DRPLA gene 1 (1.33) 0 (0.00)
   Chromosome analysis 1 (1.33) 0 (0.00)
   Unknown 1 (1.33) 2 (2.70)
 Non-hereditary ataxia 34 (45.33) 29 (39.19)
  ILOCA 34 (45.33) 29 (39.19)
Disease duration (yr) 2.33 (0.07–16.47) 3.23 (0.00–22.50) 0.4165
K-MMSE scores 28.03±1.69 27.93±2.07 0.7894

Values are presented as mean±standard deviation, number (%), or median with the range unless otherwise indicated.

* p value<0.05.

SCA, spinocerebellar ataxia; ILOCA, idiopathic late onset cerebellar ataxia; K-MMSE, Korean Mini-Mental State Examination.

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      Comments on this article

      Add a comment
      • PubReader PubReader
      • Cite
        CITE
        export Copy
        Close
      • XML DownloadXML Download
      Related articles
      Efficacy and Safety of Taltirelin Hydrate in Patients With Ataxia Due to Spinocerebellar Degeneration
      Efficacy and Safety of Taltirelin Hydrate in Patients With Ataxia Due to Spinocerebellar Degeneration
      Variables Values
      		 p value
      Taltirelin group (n=75) Control group (n=74)
      Age (yr) 56.60±10.55 52.51±12.17 0.0265*
      Sex 0.9385
       Men 40 (53.33) 39 (52.70)
       Women 35 (46.67) 35 (47.30)
      Genetic inheritance of ataxia 0.6927
       Hereditary ataxia 41 (54.67) 45 (60.81)
        SCA 37 (49.33) 42 (56.76)
        Other types of hereditary ataxia 4 (5.33) 3 (4.05)
         Spastic ataxia of Charlevoix-Saguenay 0 (0.00) 1 (1.35)
         Hereditary spastic paraplegia 1 (1.33) 0 (0.00)
         DRPLA gene 1 (1.33) 0 (0.00)
         Chromosome analysis 1 (1.33) 0 (0.00)
         Unknown 1 (1.33) 2 (2.70)
       Non-hereditary ataxia 34 (45.33) 29 (39.19)
        ILOCA 34 (45.33) 29 (39.19)
      Disease duration (yr) 2.33 (0.07–16.47) 3.23 (0.00–22.50) 0.4165
      K-MMSE scores 28.03±1.69 27.93±2.07 0.7894
      Table 1. Baseline characteristics of the patients

      Values are presented as mean±standard deviation, number (%), or median with the range unless otherwise indicated.

      p value<0.05.

      SCA, spinocerebellar ataxia; ILOCA, idiopathic late onset cerebellar ataxia; K-MMSE, Korean Mini-Mental State Examination.

      Table 1.

      JMD : Journal of Movement Disorders Twitter
      © The Korean Movement Disorder Society.
      Close layer
      TOP